BeniSuefU
Minya, Egypt
NCT Number: NCT05543577
General objective: to measure the preparedness of pharmacists and medical interns about monkeypox
Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease
Looking for future studies?
Notify MeAll sexes
Observational
Minya, Egypt
Globally, the ongoing outbreak was declared as a public health emergency. After the first laboratory-confirmed case of monkeypox was reported in Singapore on May 2019, countries all over the world started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers.
Study significance: to examine in detail the preparedness and the perception of pharmacists and medical interns about monkeypox and to evaluate the level of knowledge about monkeypox management and nature of disease.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaire
Time frame: 2 months
the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease using a validated questionnaire
Time frame: 2 months
Direct interviews with the pharmacists and medical interns to assess their knowledge and attitudes about diagnosing and dealing with the Monkeypox infected cases
Beni-Suef University
Other
Comparative Study of the Preparedness and Knowledge of Pharmacists Versus Intern Physician in the Current Monkeypox Outbreak
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05651581
Animal Diseases, DNA Virus Infections
Minneapolis, Minnesota, United States
View Trial DetailsNCT05443867
Animal Diseases, DNA Virus Infections
Antwerp, Belgium
View Trial DetailsNCT00728689
Animal Diseases, DNA Virus Infections
Orlando, Florida, United States
View Trial DetailsNCT07620600
Animal Diseases, DNA Virus Infections
View Trial Details